摘要
CyclinD1/pRb/ppRb is one of the most important pathways regulating the cell cycle, and related with the development of many cancers. However, the co-alteration of CyclinD1/pRb/ppRb in esophageal squamous cell carcinomas is less understood. This study aims to analyze the combined prognostic significance of cyclinD1 (CCND1) DNA amplification and the co-alteration of CCND1/pRb/ppRB in patients with esophageal squamous cell carcinoma. CCND1 DNA amplification and the protein expression of CCND1, pRb, and ppRb on 100 tumor specimens and 11 normal tissues were detected using real-time quantitative reverse transcription polymerase chain reaction and immunohistochemistry, respectively. Their prognosis significance was analyzed by KaplanMeier method. We found that 41% of the patients had CCND1 DNA amplification, which had a short survival time compared with the patients without CCND1 amplification (25.63 months vs. not reached, P = 0.007). The patients with the co-alternation of CCND1+/pRb/ppRb+ protein expression levels have a poorer overall survival than the others (11.4 vs. 43.4 months, P = 0.001). Cox regression analysis showed that the co-alternation of CCND1/pRb/ppRb and CyclinD1 amplification were the two most independent prognosis factors of patients with esophageal cancer. These findings suggested that CCND1 amplification and co-alternation of CCND1+/pRb/ppRb+ may play a crucial role in the prognostic evaluation of patients with esophageal cancer, and the patients with CCND1+/pRb/ppRb+ have the worst prognosis in all the patients. The results also indicated that the patients with CCND1 amplification or co-alternation of CyclinD1+/pRb/ppRb+ might be the preponderant people for therapy targeting the CCND1/pRb/ppRb pathway in the future.
学科与关键词
- Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell CarcinomaZhuang, Weitao; Ben, Xiaosong; Zhou, Zihao; Ding, Yu; Tang, Yong; Huang, Shujie; Deng, Cheng; Liao, Yuchen; Zhou, Qiaoxia; Zhao, Jing; Wang, Guoqiang; Xu, Yu; Wen, Xiaofang; Zhang, Yuzi; Cai, Shangli; Chen, Rixin*; Qiao, Guibin*Journal of Oncology, 2021, 2021: 3726058.被引 1
- PTPRO promoter methylation in peripheral blood DNA of human esophageal squamous cell carcinomaYanjie You; Yuping Chen; Hao Zhang Cancer Research Center; Cancer Hospital of Shantou; Medical College of Shantou University Dept of Integrative Traditional Chinese; Western Medicine; Cancer Hospital of Shantou; Medical College of Shantou University Dept of Thoracic Surgery; Cancer Hospital of Shantou; Medical College of Shantou University Shantou; Guangdong; China2011医学科学前沿论坛第十二届全国肿瘤药理与化疗学术会议.
- RAD6 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma by Regulating Histone Ubiquitination of CCNB1Deng, Yu; Li, Yujiang; Wu, Tiantong; Chen, Xuyuan; Li, Xiang; Cai, Kaican*; Wu, Xu*BIOLOGICAL PROCEDURES ONLINE, 2022, 24(1): 4.
